Catherine Gregor, MBA, CCRP, CCRC, Chief Clinical Trial Officer at Florence Healthcare, shares insights on how planned workforce cuts at HHS—impacting the FDA, CDC, and NIH—threaten the nation’s ability to conduct timely, innovative, patient-centered trials. The reductions could cause major delays in reviews, slow technology adoption, reduce site readiness, and disrupt the pharma pipeline. Read more in today's blog > https://bit.ly/4lgE2qx #ClinicalResearch #ClinicalTrials
